Drareg
Member
- Joined
- Feb 18, 2016
- Messages
- 4,772
A new addition courtesy of the Brandon administration, he recently worked for google health, Eric Schmidt we already know is foaming at the mouth for the global digital plantation also known as UN smart cities or the fourth industrial revolution(reich)
@haidut This sounds like just the guy to start banning b vitamins.
Robert Califf—who’s worked and lobbied for the big drug companies—looks to be the front-runner for the job.
Over the years, Califf’s industry connections have only deepened. He is now firmly situated at the intersection of Big Pharma and Big Tech as the head of “policy” and “strategy,” i.e. lobbying, for Google Health and Google’s parent company Alphabet’s subsidiary Verily Life Sciences. He’s served both organizations as a consultant since 2017 and was tapped for his current full-time role in 2019.
Google Health is currently being sued for not sufficiently anonymizing patient health data in these analytic practices, and has faced additional concern over how it and its subsidiaries handle data privacy and data security. Further, Verily is preparing for a non-Alphabet-tied IPO. Most non-Google Alphabet companies have struggled to turn a profit, but if Verily’s former lobbying strategist is put in charge of its products’ regulation and approval, it stands to benefit tremendously.
@haidut This sounds like just the guy to start banning b vitamins.
Will Biden’s FDA Be Led by a Pharma Guy?
Robert Califf—who’s worked and lobbied for the big drug companies—looks to be the front-runner for the job.
prospect.org
Robert Califf—who’s worked and lobbied for the big drug companies—looks to be the front-runner for the job.
Over the years, Califf’s industry connections have only deepened. He is now firmly situated at the intersection of Big Pharma and Big Tech as the head of “policy” and “strategy,” i.e. lobbying, for Google Health and Google’s parent company Alphabet’s subsidiary Verily Life Sciences. He’s served both organizations as a consultant since 2017 and was tapped for his current full-time role in 2019.
Google Health is currently being sued for not sufficiently anonymizing patient health data in these analytic practices, and has faced additional concern over how it and its subsidiaries handle data privacy and data security. Further, Verily is preparing for a non-Alphabet-tied IPO. Most non-Google Alphabet companies have struggled to turn a profit, but if Verily’s former lobbying strategist is put in charge of its products’ regulation and approval, it stands to benefit tremendously.